Vistra Corp. (VST) Stock Forecast
Data as of May 2, 2026Utilities · Current price $155.78 (-1.30%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | James Thalacker | BMO Capital | $241.00 | +54.7% |
| Feb 20, 2026 | David Arcaro | Morgan Stanley | $215.00 | +38.0% |
| Feb 10, 2026 | Julien Dumoulin-Smith | Jefferies | $203.00 | +30.3% |
| Feb 6, 2026 | Carly Davenport | Goldman Sachs | $205.00 | +31.6% |
| Jan 20, 2026 | Shahriar Pourreza | Wells Fargo | $236.00 | +51.5% |
| Jan 12, 2026 | Andrew Weisel | Scotiabank | $293.00 | +88.1% |
| Jan 12, 2026 | William Appicelli | UBS | $233.00 | +49.6% |
| Jan 12, 2026 | James Thalacker | BMO Capital | $244.00 | +56.6% |
| Jan 6, 2026 | James Thalacker | BMO Capital | $230.00 | +47.6% |
| Dec 16, 2025 | David Arcaro | Morgan Stanley | $228.00 | +46.4% |
| Oct 3, 2025 | James Thalacker | BMO Capital | $236.00 | +51.5% |
| Sep 22, 2025 | Andrew Weisel | Scotiabank | $256.00 | +64.3% |
| Aug 21, 2025 | David Arcaro | Morgan Stanley | $207.00 | +32.9% |
| Aug 12, 2025 | James Thalacker | BMO Capital | $229.00 | +47.0% |
| Aug 8, 2025 | Julien Dumoulin-Smith | Jefferies | $241.00 | +54.7% |
| May 15, 2025 | Durgesh Chopra | Evercore ISI | $192.00 | +23.2% |
| Oct 3, 2024 | Shelby Tucker | RBC Capital | $141.00 | -9.5% |
| Sep 23, 2024 | Julien Dumoulin-Smith | Jefferies | $137.00 | -12.1% |
| Sep 23, 2024 | David Arcaro | Morgan Stanley | $132.00 | -15.3% |
| Sep 19, 2024 | James Thalacker | BMO Capital | $125.00 | -19.8% |
Top Analysts Covering VST
VST vs Sector & Market
| Metric | VST | Utilities Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.63 | 2.41 |
| Analyst Count | 12 | 9 | 18 |
| Target Upside | +46.1% | +49.4% | +14.9% |
| P/E Ratio | 70.81 | -3.86 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $19.78B | $23.35B | $26.13B | 11 |
| 2027-12-31 | $22.14B | $25.74B | $29.38B | 10 |
| 2028-03-31 | $5.45B | $6.17B | $7.30B | 2 |
| 2028-06-30 | $7.75B | $8.78B | $10.39B | 1 |
| 2028-09-30 | $9.64B | $10.92B | $12.92B | 1 |
| 2028-12-31 | $6.84B | $7.74B | $9.17B | 2 |
| 2029-03-31 | $3.32B | $3.76B | $4.46B | 3 |
| 2029-06-30 | $4.33B | $4.90B | $5.80B | 2 |
| 2029-09-30 | $7.38B | $8.36B | $9.90B | 2 |
| 2029-12-31 | $3.80B | $4.30B | $5.09B | 3 |
| 2030-12-31 | $21.21B | $25.72B | $30.04B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $7.33 | $8.63 | $9.78 | 10 |
| 2027-12-31 | $8.65 | $11.17 | $13.26 | 9 |
| 2028-03-31 | $-0.26 | $-0.21 | $-0.18 | 2 |
| 2028-06-30 | $4.30 | $5.07 | $6.28 | 2 |
| 2028-09-30 | $4.86 | $5.73 | $7.10 | 2 |
| 2028-12-31 | $2.84 | $3.35 | $4.15 | 2 |
| 2029-03-31 | $1.14 | $1.35 | $1.67 | 1 |
| 2029-06-30 | $2.30 | $2.71 | $3.36 | 1 |
| 2029-09-30 | $5.83 | $6.87 | $8.52 | 1 |
| 2029-12-31 | $1.70 | $2.01 | $2.49 | 1 |
| 2030-12-31 | $13.17 | $17.07 | $20.79 | 5 |
Frequently Asked Questions
What is the analyst consensus for VST?
The consensus among 12 analysts covering Vistra Corp. (VST) is Buy with an average price target of $230.56.
What is the highest price target for VST?
The highest price target for VST is $293.00, set by Andrew Weisel at Scotiabank on 2026-01-12.
What is the lowest price target for VST?
The lowest price target for VST is $28.00, set by Shelby Tucker at RBC Capital on 2022-05-09.
How many analysts cover VST?
12 analysts have issued ratings for Vistra Corp. in the past 12 months.
Is VST a buy or sell right now?
Based on 12 analyst ratings, VST has a consensus rating of Buy (2.00/5) with a +46.1% upside to the consensus target of $230.56.
What are the earnings estimates for VST?
Analysts estimate VST will report EPS of $8.63 for the period ending 2026-12-31, with revenue estimated at $23.35B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.